?:authorAffiliation
|
-
[\'Inserm CIC 1432, Clinical Epidemiology/Clinical Trials Unit, Clinical Investigation Centre, Dijon University Hospital, Dijon, France; Infectious Diseases Department, Dijon University Hospital, Dijon, France; Faculty of Medicine, University of Bourgogne-Franche-Comté, Dijon, France.\', \'Biostatistics and Bioinformatics (DIM), Dijon University Hospital, Dijon, France; Faculty of Medicine, University of Bourgogne-Franche-Comté, Dijon, France.\', \'Inserm CIC 1432, Clinical Epidemiology/Clinical Trials Unit, Clinical Investigation Centre, Dijon University Hospital, Dijon, France; Biostatistics and Bioinformatics (DIM), Dijon University Hospital, Dijon, France; Faculty of Medicine, University of Bourgogne-Franche-Comté, Dijon, France.\', \'Reference Centre for Rare Pulmonary Diseases, Pulmonary Medicine and Intensive Care Unit Department, Dijon University Hospital, Dijon, France; Faculty of Medicine, University of Bourgogne-Franche-Comté, Dijon, France; Inserm LNC UMR1231, LipSTIC LabEx Team, Dijon, France.\', \'Infectious Diseases Department, Dijon University Hospital, Dijon, France.\', \'Université Paris-Saclay, UVSQ, Université Paris-Sud, Inserm, High-Dimensional Biostatistics for Drug Safety and Genomics, CESP, Villejuif, France.\', \'Inserm CIC 1432, Clinical Epidemiology/Clinical Trials Unit, Clinical Investigation Centre, Dijon University Hospital, Dijon, France; Biostatistics and Bioinformatics (DIM), Dijon University Hospital, Dijon, France; Faculty of Medicine, University of Bourgogne-Franche-Comté, Dijon, France; Université Paris-Saclay, UVSQ, Université Paris-Sud, Inserm, High-Dimensional Biostatistics for Drug Safety and Genomics, CESP, Villejuif, France. Electronic address: catherine.quantin@chu-dijon.fr.\']
|